BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 233 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,850,838 | -20.0% | 56,767 | +0.6% | 0.00% | 0.0% |
| Q2 2023 | $3,564,543 | +83.5% | 56,401 | +30.6% | 0.00% | +50.0% |
| Q1 2023 | $1,942,488 | +12.4% | 43,176 | +9.5% | 0.00% | 0.0% |
| Q4 2022 | $1,727,866 | -6.2% | 39,440 | +41.0% | 0.00% | 0.0% |
| Q3 2022 | $1,842,000 | +130.0% | 27,963 | +179.6% | 0.00% | +100.0% |
| Q4 2019 | $801,000 | -51.5% | 10,000 | -55.6% | 0.00% | -50.0% |
| Q3 2019 | $1,653,000 | -38.7% | 22,500 | -21.3% | 0.00% | -33.3% |
| Q2 2019 | $2,698,000 | +68.5% | 28,600 | +43.0% | 0.00% | +50.0% |
| Q1 2019 | $1,601,000 | +79.9% | 20,000 | +106.0% | 0.00% | +100.0% |
| Q1 2018 | $890,000 | +18.0% | 9,711 | -2.9% | 0.00% | 0.0% |
| Q4 2017 | $754,000 | +14.4% | 10,000 | -39.3% | 0.00% | 0.0% |
| Q1 2017 | $659,000 | +121.1% | 16,479 | +55.2% | 0.00% | – |
| Q4 2016 | $298,000 | – | 10,618 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |